Your browser doesn't support javascript.
loading
Single-Cell RNA Sequencing Reveals Repair Features of Human Umbilical Cord Mesenchymal Stromal Cells.
Cyr-Depauw, Chanèle; Cook, David P; Mizik, Ivana; Lesage, Flore; Vadivel, Arul; Renesme, Laurent; Deng, Yupu; Zhong, Shumei; Bardin, Pauline; Xu, Liqun; Möbius, Marius A; Marzahn, Jenny; Freund, Daniel; Stewart, Duncan J; Vanderhyden, Barbara C; Rüdiger, Mario; Thébaud, Bernard.
Afiliação
  • Cyr-Depauw C; Ottawa Hospital Research Institute, 10055, Sinclair Centre for Regenerative Medicine, Ottawa, Ontario, Canada.
  • Cook DP; University of Ottawa, 6363, Cellular and Molecular Medicine, Ottawa, Ontario, Canada.
  • Mizik I; Ottawa Hospital Research Institute, 10055, Cancer Therapeutics Program, Ottawa, Ontario, Canada.
  • Lesage F; University of Ottawa, 6363, Cellular and Molecular Medicine, Faculty of Medicine, 451 Smyth Road, Room #3206, Ottawa, Ontario, Canada.
  • Vadivel A; Ottawa Hospital Research Institute, 10055, Sinclair Centre for Regenerative Medicine, 501 Smyth road, Ottawa, Ontario, Canada.
  • Renesme L; University of Ottawa, 6363, Cellular and Molecular Medicine, Faculty of Medicine, 451 Smyth Road, Room #3206, Ottawa, Ontario, Canada.
  • Deng Y; Ottawa Hospital Research Institute, 10055, Sinclair Centre for Regenerative Medicine, 501 Smyth road, Ottawa, Ontario, Canada.
  • Zhong S; University of Ottawa, 6363, Cellular and Molecular Medicine, 451 Smyth road, Room #3206, Ottawa, Ontario, Canada.
  • Bardin P; Sinclair Centre for Regenerative Medicine, The Ottawa Hospital Research Institute (OHRI), Ottawa, Ontario, Canada.
  • Xu L; Ottawa Hospital Research Institute, 10055, Regenerative Medicine, Ottawa, Ontario, Canada.
  • Möbius MA; University of Ottawa, 6363, Cellular and Molecular Medicine, Ottawa, Ontario, Canada.
  • Marzahn J; Ottawa Health Research Institute, Ottawa, Ontario, Canada.
  • Freund D; Ottawa Hospital Research Institute, 10055, Regenerative Medicine, Ottawa, Ontario, Canada.
  • Stewart DJ; University of Ottawa, 6363, Cellular and Molecular Medicine, Ottawa, Ontario, Canada.
  • Vanderhyden BC; Ottawa Hospital Research Institute, 10055, Sinclair Centre for Regenerative Medicine, 501 Smyth road, Ottawa, Ontario, Canada.
  • Rüdiger M; Ottawa Hospital Research Institute, 10055, Regenerative Medicine, Ottawa, Ontario, Canada.
  • Thébaud B; Universitätsklinikum Carl Gustav Carus, 39063, Neonatalogy and Pediatric Critical Care Medicine, Dresden, Sachsen, Germany.
Article em En | MEDLINE | ID: mdl-38564376
ABSTRACT
RATIONALE The chronic lung disease bronchopulmonary dysplasia (BPD) is the most severe complication of extreme prematurity. BPD results in impaired lung alveolar and vascular development and long-term respiratory morbidity, for which only supportive therapies exist. Umbilical cord-derived mesenchymal stromal cells (UC-MSCs) improve lung structure and function in experimental BPD. Results of clinical trials with MSCs for many disorders do not yet match the promising preclinical studies. A lack of specific criteria to define functionally distinct MSCs persists.

OBJECTIVES:

To determine and correlate single-cell UC-MSC transcriptomic profile with therapeutic potential.

METHODS:

UC-MSCs from five term donors and human neonatal dermal fibroblasts (HNDFs, control cells of mesenchymal origin) transcriptomes were investigated by single-cell RNA sequencing analysis (scRNA-seq). The lung-protective effect of UC-MSCs with a distinct transcriptome and control HNDFs was tested in vivo in hyperoxia-induced neonatal lung injury in rats. MEASUREMENTS AND MAIN

RESULTS:

UC-MSCs showed limited transcriptomic heterogeneity, but were different from HNDFs. Gene ontology enrichment analysis revealed distinct - progenitor-like and fibroblast-like - UC-MSC subpopulations. Only the treatment with progenitor-like UC-MSCs improved lung function and structure and attenuated pulmonary hypertension in hyperoxia-exposed rat pups. Moreover, scRNA-seq identified major histocompatibility complex class I as a molecular marker of non-therapeutic cells and associated with decreased lung retention.

CONCLUSIONS:

UC-MSCs with a progenitor-like transcriptome, but not with a fibroblast-like transcriptome, provide lung protection in experimental BPD. High expression of major histocompatibility complex class I is associated with reduced therapeutic benefit. scRNA-seq may be useful to identify subsets of MSCs with superior repair capacity for clinical application.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Idioma: En Revista: Am J Respir Crit Care Med Assunto da revista: TERAPIA INTENSIVA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Idioma: En Revista: Am J Respir Crit Care Med Assunto da revista: TERAPIA INTENSIVA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Canadá